ARCHIVES

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

This article is from The Cancer Letter archive.

Vol. 33 No. 38 | October 19, 2007

Download PDF Visit The Full Archive

Related Articles

Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now

October 11, 1996

Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs.

December 15, 2000

Research Contracts Branch Reorganized, Graalman On “Detail”

October 22, 1982

NCCS Networker Volume 2 Issue 4, Fall 1988

September 13, 1988

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

Concepts Approved For Developmental Therapeutics Program

June 19, 1987